Kisspeptin: Beyond the brain

Endocrinology (United States)

Volumn 156, Issue 4, 2015, Pages 1218-1227

  Bhattacharya, Moshmi ^b,d   Babwah, Andy V ^a,b,c,d  

^a CHILDREN S HEALTH RESEARCH INSTITUTE   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^c Department of Obstetrics and Gynaecology ^*  (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR 54; KISSPEPTIN; G PROTEIN COUPLED RECEPTOR; KISS1R PROTEIN, MOUSE;

BRAIN FUNCTION; CARDIOVASCULAR SYSTEM; CELL MATURATION; CELL SURVIVAL; DECIDUALIZATION; ENDOMETRIUM; FEMALE GENITAL SYSTEM; HUMAN; HYPOPHYSIS; KIDNEY; MALE GENITAL SYSTEM; METASTASIS; NEOPLASM; NIDATION; NONHUMAN; OOCYTE; OVULATION; PANCREAS; PHYSIOLOGICAL PROCESS; PREGNANCY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SHORT SURVEY; SIGNAL TRANSDUCTION; ANIMAL; BRAIN; FEMALE; FERTILITY; GENETICS; KNOCKOUT MOUSE; MALE; METABOLISM; MOUSE; PHYSIOLOGY; REPRODUCTION;

ANIMALS; BRAIN; FEMALE; FERTILITY; KISSPEPTINS; MALE; MICE; MICE, KNOCKOUT; OVULATION; RECEPTORS, G-PROTEIN-COUPLED; REPRODUCTION; SIGNAL TRANSDUCTION;

EID: 84926433836     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1915     Document Type: Short Survey

References (91)

1. de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci U S A. 2003;100:10972-10976.
2. Seminara SB, Messager S, Chatzidaki EE, et al. The GPR54 gene as a regulator of puberty. N Engl J Med. 2003;349:1614-1627.
3. Lee JH, Miele ME, Hicks DJ, et al. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Nat Cancer Inst. 1996;88:1731-1737.
4. Ohtaki T, Shintani Y, Honda S, et al. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature. 2001;411:613-617.
5. Ji K, Ye L, Ruge F, Hargest R, Mason MD, Jiang WG. Implication of metastasis suppressor gene, Kiss-1 and its receptor Kiss-1R in colorectal cancer. BMC Cancer. 2014;14:723.
6. Schmidt E, Haase M, Ziegler E, Emons G, Grundker C. Kisspeptin-10 inhibits stromal-derived factor 1-induced invasion of human endometrial cancer cells. Int J Gynecol Cancer. 2014;24:210-217.
7. Ikeguchi M, Yamaguchi K, Kaibara N. Clinical significance of the loss of KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in esophageal squamous cell carcinoma. Clin Cancer Res. 2004;10:1379-1383.
8. Dhar DK, Naora H, Kubota H, et al. Downregulation of KiSS-1 expression is responsible for tumor invasion and worse prognosis in gastric carcinoma. Int J Canc. 2004;111:868-872.
9. Chen Y, Yusenko MV, Kovacs G. Lack of KISS1R expression is associated with rapid progression of conventional renal cell carcinomas. J Pathol. 2011;223:46-53.
10. Shoji S, Nakano M, Tomonaga T, et al. Value of metastin receptor immunohistochemistry in predicting metastasis after radical nephrectomy for pT1 clear cell renal cell carcinoma. Clin Exp Metastasis. 2013;30:607-614.
11. Yoshioka K, Ohno Y, Horiguchi Y, Ozu C, Namiki K, Tachibana M. Effects of a KiSS-1 peptide, a metastasis suppressor gene, on the invasive ability of renal cell carcinoma cells through a modulation of a matrix metalloproteinase 2 expression. Life Sci. 2008;83:332-338.
12. Shoji S, Tang XY, Umemura S, et al. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor. Eur Urol. 2009;55:441-449.
13. Sun YB, Xu S. Expression of KISS1 and KISS1R (GPR54) may be used as favorable prognostic markers for patients with non-small cell lung cancer. Int J Oncol. 2013;43:521-530.
14. Jiang Y, Berk M, Singh LS, et al. KiSS1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase C alpha. Clin Exp Metastasis. 2005;22:369-376.
15. Prentice LM, Klausen C, Kalloger S, et al. Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma. BMC Med. 2007;5:33.
16. Masui T, Doi R, Mori T, et al. Metastin and its variant forms suppress migration of pancreatic cancer cells. Biochem Biophys Res Commun. 2004;315:85-92.
17. Katagiri F, Nagai K, Kida A, et al. Clinical significance of plasma metastin level in pancreatic cancer patients. Oncol Rep. 2009;21:815-819.
18. Nagai K, Doi R, Katagiri F, et al. Prognostic value of metastin expression in human pancreatic cancer. J Exp Clin Cancer Res. 2009; 28:9.
19. McNally LR, Welch DR, Beck BH, et al. KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model. Clin Exp Metastasis. 2010;27:591-600.
20. Martinez-Fuentes AJ, Molina M, Vazquez-Martinez R, et al. Expression of functional KISS1 and KISS1R system is altered in human pituitary adenomas: Evidence for apoptotic action of kisspeptin-10. Eur J Endocrinol. 2011;164:355-362.
21. Wang H, Jones J, Turner T, et al. Clinical and biological significance of KISS1 expression in prostate cancer. Am J Pathol. 2012;180:1170-1178.
22. Ringel MD, Hardy E, Bernet VJ, et al. Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells. J Clin Endocrinol Metab. 2002;87:2399.
23. Stathatos N, Bourdeau I, Espinosa AV, et al. KiSS-1/G protein-coupled receptor 54 metastasis suppressor pathway increases myocyte-enriched calcineurin interacting protein 1 expression and chronically inhibits calcineurin activity. J Clin Endocrinol Metab. 2005; 90:5432-5440.
24. Lee JH, Welch DR. Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Res. 1997;57:2384-2387.
25. Ross DT, Scherf U, Eisen MB, et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet. 2000; 24:227-235.
26. Ellison G, Klinowska T, Westwood RF, Docter E, French T, Fox JC. Further evidence to support the melanocytic origin of MDA-MB-435. Mol Pathol. 2002;55:294-299.
27. Garraway LA, Widlund HR, Rubin MA, et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature. 2005;436:117-122.
28. Rae JM, Creighton CJ, Meck JM, Haddad BR, Johnson MD. MDA-MB-435 cells are derived from M14 melanoma cells - a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res Treat. 2007;104:13-19.
29. Zajac M, Law J, Cvetkovic DD, et al. GPR54 (KISS1R) transactivates EGFR to promote breast cancer cell invasiveness. PloS One. 2011;6:e21599.
30. Cvetkovic D, Dragan M, Leith SJ, et al. KISS1R induces invasiveness of estrogen receptor-negative human mammary epithelial and breast cancer cells. Endocrinology. 2013;154:1999-2014.
31. Cho SG, Wang Y, Rodriguez M, et al. Haploinsufficiency in the prometastasis Kiss1 receptor Gpr54 delays breast tumor initiation, progression, and lung metastasis. Cancer Res. 2011;71:6535-6546.
32. Cvetkovi D, Babwah AV, Bhattacharya M. Kisspeptin/KISS1R System in Breast Cancer. J Cancer. 2013;4:653-661.
33. Kauffman AS, Clifton DK, Steiner RA. Emerging ideas about kiss-peptin-GPR54 signaling in the neuroendocrine regulation of reproduction. Trends Neurosci. 2007;30:504-511.
34. Richard N, Corvaisier S, Camacho E, Kottler ML. KiSS-1 and GPR54at the pituitary level: Overview and recent insights. Peptides. 2009;30:123-129.
35. Gutiérrez-Pascual E, Martínez-Fuentes AJ, Pinilla L, Tena-Sempere M, Malagón MM, Castaño JP. Direct pituitary effects of kisspeptin: Activation of gonadotrophs and somatotrophs and stimulation of luteinising hormone and growth hormone secretion. J Neuroendocrinol. 2007;19:521-530.
36. Witham EA, Meadows JD, Hoffmann HM, et al. Kisspeptin regulates gonadotropin genes via immediate early gene induction in pituitary gonadotropes. Mol Endocrinol. 2013;27:1283-1294.
37. Suzuki S, Kadokawa H, Hashizume T. Direct kisspeptin-10 stimulation on luteinizing hormone secretion from bovine and porcine anterior pituitary cells. Anim Reprod Sci. 2008;103:360-365.
38. Irwig MS, Fraley GS, Smith JT, et al. Kisspeptin activation of gonadotropin releasing hormone neurons and regulation of KiSS-1 mRNA in the male rat. Neuroendocrinology. 2004;80:264-272.
39. Matsui H, Takatsu Y, Kumano S, Matsumoto H, Ohtaki T. Peripheral administration of metastin induces marked gonadotropin release and ovulation in the rat. Biochem Biophys Res Commun. 2004;320:383-388.
40. Shahab M, Mastronardi C, Seminara SB, Crowley WF, Ojeda SR, Plant TM. Increased hypothalamic GPR54 signaling: A potential mechanism for initiation of puberty in primates. Proc Natl Acad Sci U S A. 2005;102:2129-2134.
41. Navarro VM, Castellano JM, Fernández-Fernández R, et al. Effects of KiSS-1 peptide, the natural ligand of GPR54, on follicle-stimulating hormone secretion in the rat. Endocrinology. 2005;146:1689-1697.
42. Kaiser UB, Conn PM, Chin WW. Studies of gonadotropin-releasing hormone (GnRH) action using GnRH receptor-expressing pituitary cell lines. Endocr Rev. 1997;18:46-70.
43. Terao Y, Kumano S, Takatsu Y, Hattori M, Nishimura A, Ohtaki T, Shintani Y. Expression of KiSS-1, a metastasis suppressor gene, in trophoblast giant cells of the rat placenta. Biochim Biophys Acta. 2004;1678:102-110.
44. Castellano JM, Gaytan M, Roa J, et al. Expression of KiSS-1 in rat ovary: Putative local regulator of ovulation? Endocrinology. 2006; 147:4852-4862.
45. Gaytán F, Gaytán M, Castellano JM, et al. KiSS-1 in the mammalian ovary: Distribution of kisspeptin in human and marmoset and alterations in KiSS-1 mRNA levels in a rat model of ovulatory dysfunction. Am J Physiol Endocrinol Metab. 2009;296:E520-E531.
46. Gaytán M, Castellano JM, Roa J, Sanchez-Criado JE, Tena-Sempere M, Gaytan F. Expression of KiSS-1 in rat oviduct: Possible involvement in prevention of ectopic implantation? Cell Tissue Res. 2007; 329:571-579.
47. Shahed A, Young KA. Differential ovarian expression of KiSS-1 and GPR-54 during the estrous cycle and photoperiod induced recrudescence in Siberian hamsters (Phodopus sungorus). Mol Reprod Dev. 2009;76:444-452.
48. Cejudo Roman A, Pinto FM, Dorta I, et al. Analysis of the expression of neurokinin B, kisspeptin, and their cognate receptors NK3R and KISS1R in the human female genital tract. Fertil Steril. 2012;97:1213-1219.
49. Gaytán F, Garcia-Galiano D, Dorfman MD, et al. Kisspeptin receptor haplo-insufficiency causes premature ovarian failure despite preserved gonadotropin secretion. Endocrinology. 2014;155:3088-3097.
50. Calder M, Chan YM, Raj R, et al. Implantation failure in female Kiss1-/- mice is independent of their hypogonadic state and can be partially rescued by leukemia inhibitory factor. Endocrinology. 2014;155:3065-3078.
51. Dorfman MD, Garcia-Rudaz C, Alderman Z, et al. Loss of Ntrk2/ Kiss1r signaling in oocytes causes premature ovarian failure. Endocrinology. 2014;155:3098-3111.
52. Coulam CB, Chapman C, Rinehart JS. What is a preclinical pregnancy loss? J Assist Reprod Genet. 1998;15:184-187.
53. Bentin-Ley U, Horn T, Sjögren A, et al. Ultrastructure of human blastocyst-endometrial interactions in vitro. J Reprod Fertil. 2000; 120:337-350.
54. Taylor J, Pampillo M, Bhattacharya M, Babwah AV. Kisspeptin/ KISS1R signaling potentiates extravillous trophoblast adhesion to type-I collagen in a PKC- and ERK1/2-dependent manner. Mol Reprod Dev. 2014;81:42-54.
55. Bhatt H, Brunet LJ, Stewart CL. Uterine expression of leukemia inhibitory factor coincides with the onset of blastocyst implantation. Proc Natl Acad Sci U S A. 1991;88:11408-11412.
56. Dey SK, Lim H, Das SK, et al. Molecular cues to implantation. Endocr Rev. 2004;25:341-373.
57. Zhang P, Tang M, Zhong T, et al. Expression and function of kisspeptin during mouse decidualization. PloS One. 2014;9:e97647.
58. Bilban M, Ghaffari-Tabrizi N, Hintermann E, et al. Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts. J Cell Sci. 2004;117: 1319-1328.
59. Kotani M, Detheux M, Vandenbogaerde A, et al. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem. 2001; 276:34631-34636.
60. Muir AI, Chamberlain L, Elshourbagy NA, et al. AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem. 2001;276:28969-28975.
61. Janneau JL, Maldonado-Estrada J, Tachdjian G, et al. Transcriptional expression of genes involved in cell invasion and migration by normal and tumoral trophoblast cells. J Clin Endocrinol Metab. 2002;87:5336-5339.
62. Horikoshi Y, Matsumoto H, Takatsu Y, et al. Dramatic elevation of plasma metastin concentrations in human pregnancy: Metastin as a novel placenta-derived hormone in humans. J Clin Endocrinol Metab. 2003;88:914-919.
63. Roseweir AK, Katz AA, Millar RP. Kisspeptin-10 inhibits cell migration in vitro via a receptor-GSK3 beta-FAK feedback loop in HTR8SVneo cells. Placenta. 2012;33:408-415.
64. Herreboudt AM, Kyle VR, Lawrence J, Doran J, Colledge WH. Kiss1 mutant placentas show normal structure and function in the mouse. Placenta. 2015;36:52-58.
65. Charnock-Jones DS, Kaufmann P, Mayhew TM. Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation. Placenta. 2004;25:103-113.
66. Huppertz B, Peeters LL. Vascular biology in implantation and placentation. Angiogenesis. 2005;8:157-167.
67. Ramaesh T, Logie JJ, Roseweir AK, et al. Kisspeptin-10 inhibits angiogenesis in human placental vessels ex vivo and endothelial cells in vitro. Endocrinology. 2010;151:5927-5934.
68. Kaufmann P, Mayhew TM, Charnock-Jones DS. Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy. Placenta. 2004;25:114-126.
69. Jayasena CN, Nijher GM, Chaudhri OB, et al. Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis. J Clin Endocrinol Metab. 2009;94:4315-4323.
70. Pampillo M, Camuso N, Taylor JE, et alV. Regulation of GPR54 signaling by GRK2 and {beta}-arrestin. Mol Endocrinol. 2009;23:2060-2074.
71. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ. Regulation of human placental development by oxygen tension. Science. 1997;277:1669-1672.
72. Cavanagh PC, Dunk C, Pampillo M, et al. Gonadotropin-releasing hormone-regulated chemokine expression in human placentation. Am J Physiol Cell Physiol. 2009;297:C17-C27.
73. Hauge-Evans AC, Richardson CC, Milne HM, Christie MR, Persaud SJ, Jones PM. A role for kisspeptin in islet function. Diabetologia. 2006;49:2131-2135.
74. Cetkovi A, Miljic D, Ljubi A, et al. Plasma kisspeptin levels in pregnancies with diabetes and hypertensive disease as a potential marker of placental dysfunction and adverse perinatal outcome. Endocr Res. 2012;37:78-88.
75. Pinto FM, Cejudo-Román A, Ravina CG, et al. Characterization of the kisspeptin system in human spermatozoa. Int J Androl. 2012; 35:63-73.
76. Mei H, Doran J, Kyle V, Yeo SH, Colledge WH. Does Kisspeptin Signaling have a Role in the Testes? Front Endocrinol (Lausanne). 2013;4:198.
77. Hsu MC, Wang JY, Lee YJ, Jong DS, Tsui KH, Chiu CH. Kisspeptin modulates fertilization capacity of mouse spermatozoa. Reproduction. 2014;147:835-845.
78. Wahab F, Riaz T, Shahab M. Study on the effect of peripheral kiss-peptin administration on basal and glucose-induced insulin secretion under fed and fasting conditions in the adult male rhesus monkey (Macaca mulatta). Horm Metab Res. 2011;43:37-42.
79. Bowe JE, King AJ, Kinsey-Jones JS, et al. Kisspeptin stimulation of insulin secretion: Mechanisms of action in mouse islets and rats. Diabetologia. 2009;52:855-862.
80. Bowe JE, Foot VL, Amiel SA, et al. GPR54 peptide agonists stimulate insulin secretion from murine, porcine and human islets. Islets. 2012;4:20-23.
81. Silvestre RA, Egido EM, Hernández R, Marco J. Kisspeptin-13 inhibits insulin secretion without affecting glucagon or somatostatin release: Study in the perfused rat pancreas. J Endocrinol. 2008;196:283-290.
82. Vikman J, Ahren B. Inhibitory effect of kisspeptins on insulin secretion from isolated mouse islets. Diabetes Obes Metab. 2009; 11(Suppl 4):197-201.
83. Tolson KP, Garcia C, Yen S, et al. Impaired kisspeptin signaling decreases metabolism and promotes glucose intolerance and obesity. J Clin Invest. 2014;124:3075-3079.
84. Cho SG, Yi Z, Pang X, et al. Kiss peptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activation. Cancer Res. 2009;69:7062-7070.
85. Mead EJ, Maguire JJ, Kuc RE, Davenport AP. Kisspeptins are novel potent vasoconstrictors in humans, with a discrete localization of their receptor, G protein-coupled receptor 54, to atherosclerosisprone vessels. Endocrinology. 2007;148:140-147.
86. Maguire JJ, Kirby HR, Mead EJ, et al. Inotropic action of the puberty hormone kisspeptin in rat, mouse and human: Cardiovascular distribution and characteristics of the kisspeptin receptor. PloS One. 2011;6:e27601.
87. Shoji I, Hirose T, Mori N, et al. Expression of kisspeptins and kisspeptin receptor in the kidney of chronic renal failure rats. Peptides. 2010;31:1920-1925.
88. Yi T, Tan K, Cho SG, et al. Regulation of embryonic kidney branching morphogenesis and glomerular development by KISS1 receptor (Gpr54) through NFAT2- and Sp1-mediated Bmp7 expression. J Biol Chem. 2010;285:17811-17820.
89. Kirilov M, Clarkson J, Liu X, et al. Dependence of fertility on kiss-peptin-Gpr54 signaling at the GnRH neuron. Nat Commun. 2013; 4:2492.
90. Novaira HJ, Sonko ML, Hoffman G, et al. Disrupted kisspeptin signaling in GnRH neurons leads to hypogonadotrophic hypogonadism. Mol Endocrinol. 2014;28:225-238.
91. Roseweir AK, Kauffman AS, Smith JT, et al. Discovery of potent kisspeptin antagonists delineate physiological mechanisms of gonadotropin regulation. J Neurosci. 2009;29:3920-3929.